Sona Ciernikova

Mar 14, 2023 | frontiersin.org | Universidad UTE |Ana Karina |Jinbo Xiong |Sona Ciernikova

IntroductionHematologic malignancies are characterized by the uncontrolled growth of hematopoietic and lymphoid cells, resulting in decreased immune system efficacy (Méndez-Ferrer et al., 2020). Hematologic neoplasms account for 6.5% of all cancers worldwide (De Moraes Hungria et al., 2019; Kocarnik et al., 2022). The World Health Organization (WHO) classifies hematologic malignancies based on morphology, immunophenotype, genetics, and clinical features (Khoury et al., 2022).